tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

LLY Stock Latest News

Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
The FlySector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
7h ago
ABT
BMY
Novo Nordisk price target lowered to $110 from $140 at Argus
PremiumThe Fly
Novo Nordisk price target lowered to $110 from $140 at Argus
14h ago
LLY
NVO
Novo Nordisk’s (NYSE:NVO) Ozempic and Wegovy Lined Up for Medicare Drug Price Negotiations
PremiumMarket News
Novo Nordisk’s (NYSE:NVO) Ozempic and Wegovy Lined Up for Medicare Drug Price Negotiations
14h ago
AZN
BMY
Eli Lilly price target lowered to $973 from $995 at Guggenheim
PremiumThe Fly
Eli Lilly price target lowered to $973 from $995 at Guggenheim
16h ago
LLY
Insulin prices have dropped but some poor patients are paying more, NYT says
PremiumThe Fly
Insulin prices have dropped but some poor patients are paying more, NYT says
2d ago
LLY
NVO
Eli Lilly price target lowered to $970 from $1,050 at Berenberg
PremiumThe FlyEli Lilly price target lowered to $970 from $1,050 at Berenberg
2d ago
LLY
Eli Lilly’s Omvoh for Crohn’s disease approved by FDA
Premium
The Fly
Eli Lilly’s Omvoh for Crohn’s disease approved by FDA
2d ago
LLY
Eli Lilly Q4 miss brings buying opportunity, says JPMorgan
Premium
The Fly
Eli Lilly Q4 miss brings buying opportunity, says JPMorgan
3d ago
LLY
Leerink remains bullish on Eli Lilly despite lower Q4 revenue guidance
PremiumThe Fly
Leerink remains bullish on Eli Lilly despite lower Q4 revenue guidance
3d ago
LLY
Lilly cuts FY24 outlook, United Rentals to acquire H&E: Morning Buzz
PremiumThe Fly
Lilly cuts FY24 outlook, United Rentals to acquire H&E: Morning Buzz
3d ago
V
MA
Eli Lilly (NYSE:LLY) Shares Plunge as Q4 Guidance Disappoints
PremiumMarket News
Eli Lilly (NYSE:LLY) Shares Plunge as Q4 Guidance Disappoints
3d ago
LLY
Eli Lilly falls -6.5%
PremiumThe Fly
Eli Lilly falls -6.5%
4d ago
LLY
Drugmakers to push Trump to pause price negotiations, Bloomberg reports
PremiumThe FlyDrugmakers to push Trump to pause price negotiations, Bloomberg reports
4d ago
AZN
BMY
Eli Lilly sees growth in 2025 from new medicines
Premium
The Fly
Eli Lilly sees growth in 2025 from new medicines
4d ago
LLY
Eli Lilly cuts FY24 revenue view to ~$45B from $45.4B-$46B, consensus $45.55B
Premium
The Fly
Eli Lilly cuts FY24 revenue view to ~$45B from $45.4B-$46B, consensus $45.55B
4d ago
LLY
Eli Lilly sees FY25 revenue $58B-$61B, consensus $58.48B
PremiumThe Fly
Eli Lilly sees FY25 revenue $58B-$61B, consensus $58.48B
4d ago
LLY
Eli Lilly sees Q4 worldwide revenue ~$13.5B, consensus $13.95B
PremiumThe Fly
Eli Lilly sees Q4 worldwide revenue ~$13.5B, consensus $13.95B
4d ago
LLY
Eli Lilly (LLY) Expects Weight-Loss Pill Approval in 2026
PremiumMarket News
Eli Lilly (LLY) Expects Weight-Loss Pill Approval in 2026
4d ago
LLY
NVO
Eli Lilly CEO tells Bloomberg TV company sees weight loss pill approval in 2026
PremiumThe Fly
Eli Lilly CEO tells Bloomberg TV company sees weight loss pill approval in 2026
4d ago
LLY
Eli Lilly to acquire Scorpion Therapeutics’ STX-478 program for up to $2.5B
PremiumThe FlyEli Lilly to acquire Scorpion Therapeutics’ STX-478 program for up to $2.5B
5d ago
LLY
Verve Therapeutics announces anticipated 2025 milestones
Premium
The Fly
Verve Therapeutics announces anticipated 2025 milestones
5d ago
LLY
VERV
Potential acquisition of Scorpion positive for Relay, says Barclays
Premium
The Fly
Potential acquisition of Scorpion positive for Relay, says Barclays
6d ago
LLY
RLAY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >